Genertec Universal Medical Group Company Limited

HKEX:2666.HK

4.41 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Revenue 6,898.0636,520.9876,169.4855,560.9034,744.1374,822.7694,351.9953,891.2393,552.4923,194.322,200.3012,094.7121,770.61,653.381,457.4431,251.2721,213.151982.051883.781672.98388.171
Cost of Revenue -45.0730164.579000000000000000221.213154.899154.899
Gross Profit 6,943.1366,520.9876,004.9065,560.9034,744.1374,822.7694,351.9953,891.2393,552.4923,194.322,200.3012,094.7121,770.61,653.381,457.4431,251.2721,213.151982.051662.568518.082233.272
Gross Profit Ratio 1.00710.9731111111111111110.750.770.601
Reseach & Development Expenses 29.0236.85241.7646.30918.4127.4328.1238.50613.825000000000000
General & Administrative Expenses 630.17538.266473.311440.686359.738380.016357.404256.464258.842182.566135.898108.45274.233115.387158.207119.025144.872101.624118.4272.19447.654
Selling & Marketing Expenses 237.395159.773215.81225.793201.325260.68199.861180.529232.124172.465216.035171.216176.287157.916156.76120.491140.90173.02573.21853.07731.574
SG&A 867.565698.039689.121666.479561.063640.696557.265436.993490.966355.031351.933279.668250.52273.303314.967239.516285.773174.649184.624132.28579.227
Other Expenses 000000000000000000-0.1-1.189-1.189
Operating Expenses 5,595.3454,957.4924,971.0134,056.1013,527.8433,347.2553,115.1742,763.0462,534.6482,000.3051,342.9211,093.053994.047853.472798.345704.425680.626614.302508.799436.8878.038
Operating Income 1,322.4291,452.6731,233.0841,562.8261,112.1521,538.1611,137.8311,143.882975.3871,288.923910.7331,047.237849.735805.782641.862546.4483.739366.19356.125264.133152.771
Operating Income Ratio 0.1920.2230.20.2810.2340.3190.2610.2940.2750.4040.4140.50.480.4870.440.4370.3990.3730.4030.3920.394
Total Other Income Expenses Net -19.711110.822-34.612-58.024104.142-62.64798.99-15.68942.457-94.908-53.353-45.578-73.182-5.87417.2360.44748.7861.55918.857-28.0330
Income Before Tax 1,302.7181,563.4951,198.4721,504.8021,216.2941,475.5141,236.8211,128.1931,017.8441,194.015857.381,001.659776.553799.908659.098546.847532.525367.749374.982236.1152.771
Income Before Tax Ratio 0.1890.240.1940.2710.2560.3060.2840.290.2870.3740.390.4780.4390.4840.4520.4370.4390.3740.4240.3510.394
Income Tax Expense 297.228369.913288.884328.442311.348349.991283.889267.215255.977321.49239.969268.406206.789220.993176.333157.302143.91397.83593.83960.60538.611
Net Income 927.7431,093.175799.0521,089.365785.2771,049.956854.135793.402676.751811.985616.641735.532569.705578.953482.765389.545388.612269.914281.143175.495114.16
Net Income Ratio 0.1340.1680.130.1960.1660.2180.1960.2040.1910.2540.280.3510.3220.350.3310.3110.320.2750.3180.2610.294
EPS 0.460.530.390.530.390.530.50.460.390.470.360.430.330.340.280.230.230.210.280.220.09
EPS Diluted 0.450.520.380.530.380.520.50.460.390.470.360.430.330.340.280.230.230.210.280.220.09
EBITDA -97.45810.415-145.148-145.019-15.527-138.2140.193-83.265-42.659-155.448-54.123-43.299-73.241-5.83617.2360.44748.7861.55918.857-28.033156.558
EBITDA Ratio -0.0140.002-0.024-0.026-0.003-0.0290-0.021-0.012-0.049-0.025-0.021-0.041-0.0040.01200.040.0020.021-0.0420.403